China High Quality 99% Purity CAS 184475-35-2 Sorafenib Tosylate Anti-Cancer Raw Powder, Find details about China Sorafenib Tosylate, Sorafenib from High Quality 99% Purity CAS 184475-35-2 Sorafenib Tosylate Anti-Cancer Raw Powder
Product Description
Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
Product | CAS |
Erlotinib hydrochloride | 183319-69-9 |
Dasatinib | 302962-49-8 |
Gefitinib | 184475-35-2 |
Sunitinib Malate | 341031-54-7 |
Sorafenib tosylate | 475207-59-1 |
Lapatinib | 231277-92-2 |
Nilotinib | 641571-10-0 |
Bosutinib | 380843-75-4 |
Ibrutinib | 936563-96-1 |
Palbociclib(PD0332991) | 571190-30-2 |
Lenvatinib | 417716-92-8 |
Crizotinib | 877399-52-5 |
Afatinib | 850140-72-6 |
Imatinib mesylate | 220127-57-1 |
BIBW2992 DiMaleate | 850140-73-7 |
Unii-33Y9anm545 | 635702-64-6 |
Ruxolitinib phosphate | 1092939-17-7 |
Vandetanib | 443913-73-3 |
VeMurafenib | 918504-65-1 |
Regorafenib Monohydrate | 1019206-88-2 |
Cabozantinib Malate | 1140909-48-3 |
Axitinib | 319460-85-0 |
Ponatinib Hydrochloride | 1114544-31-8 |
GSK1120212 (DMSO solvate) | 1187431-43-1 |
Dabrafenib Mesylate(GSK-2118436B) | 1195768-06-9 |
CAL-101 | 870281-82-6 |
Apatinib | 1218779-75-9 |
Ceritinib (LDK378) | 1032900-25-6 |